Ozempic and Wegovy maker sues over compounded, off-brand versions of drugs used for weight loss

Argentina Noticias Noticias

Ozempic and Wegovy maker sues over compounded, off-brand versions of drugs used for weight loss
Argentina Últimas Noticias,Argentina Titulares
  • 📰 ABC
  • ⏱ Reading Time:
  • 9 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 7%
  • Publisher: 51%

Novo Nordisk, the pharmaceutical company that makes Ozempic and Wegovy, has filed multiple lawsuits against off-brand versions of the wildly popular drugs.

Sign up for our newsletters to get GMA delivered to your inbox every morning!

Novo Nordisk, the pharmaceutical company that makes Ozempic and Wegovy, filed multiple lawsuits Tuesday against off-brand versions of the wildly popular drugs.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

ABC /  🏆 471. in US

Argentina Últimas Noticias, Argentina Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

Novo Nordisk sues clinics allegedly selling copycat versions of Ozempic and WegovyNovo Nordisk sues clinics allegedly selling copycat versions of Ozempic and WegovyNovo Nordisk says it filed lawsuits against multiple medical spas, weight loss clinics and compounding pharmacies for allegedly selling unauthorized versions of the drugmaker's popular medicines Ozempic and Wegovy.
Leer más »

Novo Nordisk sues clinics allegedly selling knockoff versions of Ozempic and WegovyNovo Nordisk sues clinics allegedly selling knockoff versions of Ozempic and WegovyDanish drugmaker Novo Nordisk initiated federal court lawsuits against medical spas and wellness clinics in New York, Texas, Florida and Tennessee.
Leer más »

Drugmaker behind Ozempic, Wegovy begins legal proceedings against certain med spas, clinics and compounding pharmacies | CNNDrugmaker behind Ozempic, Wegovy begins legal proceedings against certain med spas, clinics and compounding pharmacies | CNNPharmaceutical firm Novo Nordisk says it has begun legal proceedings against some US medical spas, weight loss or wellness clinics and compounding pharmacies “to cease and desist from false advertising, trademark infringement and/or unlawful sales of non-FDA approved compounded products claiming to contain semaglutide,” the active ingredient in its diabetes and weight-loss medications Ozempic, Wegovy and Rybelsus.
Leer más »

Novo Nordisk cracks down on alleged Ozempic imitationsNovo Nordisk cracks down on alleged Ozempic imitationsDrug maker Novo Nordisk on Tuesday sued five wellness spas and clinics in federal court, accusing them of unlawfully peddling what they said were modified...
Leer más »

Why won't your company pay for weight-loss drugs like WegovyInsider tells the global tech, finance, markets, media, healthcare, and strategy stories you want to know.
Leer más »

Ozempic users spark spike in ER visits: Shocking new side effectsOzempic users spark spike in ER visits: Shocking new side effectsThis celebrity-hyped injectable could cause cancer, blurred vision, pancreatitis, and gallstones — so is it really worth shooting your shot?
Leer más »



Render Time: 2025-03-31 17:49:42